Overall, the contribution of CD19− Pop 4/5 to the circulating ASC pool was greatly increased in both SLE groups relative to vax-HC, where they are scarcely detected, consistent with previous studies2,10 (Fig. 2). This evidence concerns the gene CD19 and systemic lupus erythematosus.